iRGD line peptide

iRGD linear peptide is a specialized peptide sequence renowned for its unique tumor-penetrating and tissue-targeting properties, making it a valuable tool in various biomedical research settings. Characterized by its distinct RGD motif and a C-end Rule (CendR) sequence, iRGD linear peptide has garnered significant attention for its ability to facilitate the targeted delivery of molecules across biological barriers. Its structure enables it to selectively bind to integrins and neuropilin-1 receptors, which are often overexpressed in certain pathological tissues. As a result, it serves as a versatile molecular tool for researchers seeking to enhance the specificity and efficiency of therapeutic and diagnostic agents in preclinical studies. The peptide's adaptability allows it to be conjugated to a wide range of cargos, including nanoparticles, small molecules, and imaging agents, thereby expanding its utility across multiple research domains.

Targeted Drug Delivery: iRGD linear peptide is extensively utilized in the development of targeted drug delivery systems. By leveraging its high affinity for integrins and neuropilin-1, the peptide facilitates the transport of therapeutic agents directly to desired tissues, thereby increasing local concentration while minimizing off-target effects. The mechanism involves a multi-step process where the peptide first binds to integrins, followed by proteolytic cleavage that exposes the CendR motif, which then interacts with neuropilin-1 to enhance tissue penetration. This dual-receptor targeting capability has enabled researchers to design delivery platforms that achieve superior tissue specificity and penetration, optimizing the efficacy of experimental therapeutics in vitro and in vivo.

Nanoparticle Functionalization: In the realm of nanotechnology, iRGD linear peptide serves as a functionalization agent for a variety of nanoparticles. When conjugated to the surface of liposomes, polymeric nanoparticles, or inorganic nanocarriers, it significantly improves their ability to home in on target tissues and traverse biological barriers. This property is particularly valuable for the delivery of imaging probes or therapeutic payloads, as it increases their accumulation in specific microenvironments. Researchers have demonstrated that iRGD-modified nanoparticles exhibit enhanced internalization and distribution within target tissues, thereby advancing the development of next-generation delivery vehicles for research purposes.

Imaging Agent Enhancement: The unique targeting ability of iRGD linear peptide is also harnessed to improve the performance of molecular imaging agents. By attaching the peptide to fluorescent dyes, radiotracers, or MRI contrast agents, scientists can achieve heightened imaging contrast and specificity in preclinical models. This targeted approach not only allows for more precise visualization of tissues of interest but also reduces background noise, leading to clearer and more informative imaging results. As a result, iRGD-conjugated imaging agents are valuable tools for studying tissue distribution, disease progression, and the biodistribution of experimental compounds.

Cellular Uptake Studies: Researchers employ iRGD linear peptide in cellular uptake and penetration assays to investigate its mechanism of action and to evaluate the efficiency of various delivery systems. The peptide's ability to trigger transcytosis and enhance cellular entry is studied using both two-dimensional cell cultures and three-dimensional tissue models. These studies provide critical insights into the pathways involved in peptide-mediated transport and inform the design of more effective delivery strategies. The data generated from such research contribute to a deeper understanding of tissue-specific uptake mechanisms and the potential for overcoming biological barriers.

Therapeutic Conjugate Development: iRGD linear peptide is frequently used as a linker or targeting moiety in the synthesis of therapeutic conjugates. By covalently attaching experimental drugs, peptides, or oligonucleotides to the peptide, researchers can create multifunctional conjugates that combine the targeting and penetrative properties of iRGD with the biological activity of the payload. This approach enables the development of innovative research tools for probing biological processes and testing new therapeutic concepts in laboratory settings. The versatility and specificity of iRGD linear peptide continue to drive advancements in the field of targeted delivery and molecular engineering.

Peptide Engineering Research: The study and modification of iRGD linear peptide itself represent a significant research direction. Scientists explore sequence variations, structure-activity relationships, and conjugation strategies to further enhance its targeting efficiency and stability. These investigations not only improve the performance of the peptide in delivery and imaging applications but also contribute to the broader understanding of peptide-based targeting mechanisms. As a result, ongoing research into iRGD and its derivatives is instrumental in expanding the toolbox of molecular strategies available for biomedical investigation and technological innovation.

1. Crystal Structure of BamB from Pseudomonas aeruginosa and Functional Evaluation of Its Conserved Structural Features

2. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

3. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency

4. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

5. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats